BioSpace News Archive

Fapon Biotech Inc., a global leading IVD raw materials and one-stop solutions company offering products and technologies to enable the rapid development and production of reagents, initiated a global donation to give a total of 3 million PCR test components to IVD partners.

Saama Technologies, Inc. (“Saama”), the #1 AI clinical analytics platform company, announced today that it will contribute its AI-powered Life Science Analytics Cloud (LSAC) technology platform to establish the EndPandemic National Data Consortium.

Endologix, Inc., a developer and marketer of innovative treatments for aortic disorders, announced the grant of inducement equity awards to two newly hired employees.

One of the largest health systems in the U.S. rapidly deploys digital health solution to combat pandemic.

VANCOUVER, British Columbia, March 30, 2020 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “ Company ” or “ Algernon ”) a clinical stage pharmaceutical development company, is pleased to announce that it has submitted for ethics approval in Australia for its planned Phase 2 study of its re-purposed drug NP-120 (Ifenprodil) for idiopathic pulmonary fibrosis (IPF) and chronic cough . Ethics submission is the next step in the company’s clinica

On Sunday March 29, 2020 - The Company Set New Daily Records for: Revenue Generated and Number of Individual Transactions

OssDsign AB (publ) today announced that the Japanese Pharmaceuticals and Medical Devices Agency (PMDA) has granted approval of OssDsign Cranial PSI for the Japanese market.

Charles River Laboratories International, Inc. (NYSE: CRL) today announced that it has entered into a partnership with Deciphex, a leader in preclinical digital pathology software-as-a-service.

In the wake of the global COVID-19 Lockdown, SpendEdge, a global procurement market intelligence firm, has announced the availability of a team of experts dedicated to addressing the emerging supply chain queries in the pharmaceutical industry.

Pendulum Therapeutics , an evidence-based microbiome company, announced today that veteran health care executive Heather Mason has joined its board of directors. A global executive with more than 25 years of experience in bringing novel pharmaceutical and consumer products to battle chronic diseases, including diabetes, Mason brings a wealth of expertise to Pendulum Therapeutics’ fast-growing business. Mason most recently served as executi